Maeyama, Akira
Kondo, Masakazu
Harada, Hiroshi
Shono, Eisuke
Nagamine, Ryuji
Tsuru, Tomomi
Inoue, Yasushi
Nakashima, Munetoshi
Yamasaki, Yutaro
Niiro, Hiroaki
Nakashima, Yasuharu
Yamamoto, Takuaki
Article History
Received: 2 August 2024
Accepted: 6 December 2024
First Online: 18 December 2024
Declarations
:
: This study was conducted with the approval of the Ethics Review Committee (Haradoi Hospital Ethical Review Board: Approval No. 2019006). This study is a multicenter study. In addition, Haradoi Hospital was the institute of the Ethical Review Committee decided by the Kondo Clinic of Rheumatology and Orthopaedic Surgery, the lead institution of the study. All the patients provided informed verbal consent to participate in this study. The procedure of obtaining informed verbal consent was approved by Haradoi Hospital Ethical Review Board.
: Not applicable.
: HN has received lecture fees or grants from Asahi Kasei Pharma Corporation, Eisai Co., Ltd., GlaxoSmithKline K.K., Bristol Myers Squibb, Nippon Boehringer Ingelheim Co., Ltd. and Chugai Pharmaceutical Co., Ltd. The other authors have no competing interests to declare.